Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 1.00 |
| ▸ | CNR2 | P34972 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.68 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29380189 | 1.00 | CNR1 (1.00) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL25383045 | 0.94 | CNR1 (0.88) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| Sulfur Dioxide SCHEMBL20526191 | 0.92 | CNR1 (0.85) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL721719 | 0.90 | CNR1 (0.81) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL723543 | 0.87 | CNR1 (0.77) | CNR1CNR2ALOX5KDM4EALDH1A1 | |
| SCHEMBL8940661 | 0.86 | CNR1 (0.73) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL7747447 | 0.86 | GABRA1 (0.77) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL7080953 | 0.85 | CNR1 (0.72) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL167391 | 0.85 | CNR1 (0.72) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL12881959 | 0.84 | CNR1 (0.71) | CNR1CNR2ALOX5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022226857-A1 | WET DRESSING FOR TATTOO COLOR PROTECTION AND USING METHOD THEREFOR | 美丽康生技股份有限公司 | 2022-11-03 | — | — | WO | claimed |
| EP-3763396-A1 | METHOD FOR COLOR MAINTENANCE AND ENHANCEMENT OF TATTOO | MLK Bioscience Co., Ltd. (TW) | 2021-01-13 | — | — | EP | claimed |
| EP-2794534-B1 | PROCESSES FOR MAKING MAGNOLOL AND DERIVATIVES THEREOF | COLGATE PALMOLIVE CO (US) | 2016-11-30 | — | — | EP | claimed |
| EP-2794535-B1 | PROCESSES FOR MAKING MAGNOLOL ANALOGS | COLGATE PALMOLIVE CO (US) | 2016-04-20 | — | — | EP | claimed |
| US-9045397-B2 | Processes for making magnolol analogs | COLGATE-PALMOLIVE COMPANY (US) | 2015-06-02 | — | — | US | claimed |
| US-9000231-B2 | Processes for making magnolol and derivatives thereof | COLGATE-PALMOLIVE COMPANY (US) | 2015-04-07 | — | — | US | claimed |
| US-20140357902-A1 | PROCESSES FOR MAKING MAGNOLOL AND DERIVATIVES THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2014-12-04 | — | — | US | claimed |
| US-20140343328-A1 | PROCESSES FOR MAKING MAGNOLOL ANALOGS | COLGATE-PALMOLIVE COMPANY (US) | 2014-11-20 | — | — | US | claimed |
| EP-2794534-A1 | PROCESSES FOR MAKING MAGNOLOL AND DERIVATIVES THEREOF | Colgate-Palmolive Company (US) | 2014-10-29 | — | — | EP | claimed |
| WO-2013095361-A1 | PROCESSES FOR MAKING MAGNOLOL AND DERIVATIVES THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2013-06-27 | — | — | WO | claimed |
| EP-4262528-B1 | DEVICE AND METHOD FOR CONTINUOUS EVEN APPLICATION OF COMPOSITION TO SKIN | KENVUE BRANDS LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12472336-B2 | System and method for selective application of cosmetic composition to impart undereye brightening | KENVUE BRANDS LLC (US) | 2025-11-18 | — | — | US | disclosed |
| EP-3389595-B1 | COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC ACID HAVING TWO OR MORE ACID DISSOCIATION CONSTANTS | OREAL (FR) | 2025-11-05 | — | — | EP | disclosed |
| EP-4234042-B1 | MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR | POLA CHEM IND INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-12358008-B2 | Device for supplying a composition to a pressurized deposition system | KENVUE BRANDS LLC (US) | 2025-07-15 | — | — | US | disclosed |
| WO-2011102001-A1 | COSMETIC COMPOSITION | L'OREAL (FR) | 2011-08-25 | — | — | WO | disclosed |
| EP-2042153-A1 | SKIN COSMETIC | Kao Corporation (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-20090053152-A1 | SKIN COSMETIC | KAO CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| JP-2006325441-A | METHOD FOR PRODUCING 2,2'-DIHYDROXY-5,5'-DIPROPYLBIPHENYL | T HASEGAWA CO LTD | 2006-12-07 | — | — | JP | disclosed |
| JP-2006325441-A | METHOD FOR PRODUCING 2,2'-DIHYDROXY-5,5'-DIPROPYLBIPHENYL | T HASEGAWA CO LTD | 2006-12-07 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357902-A1 | PROCESSES FOR MAKING MAGNOLOL AND DERIVATIVES THEREOF | ADRB2, ADRB1, CYP4B1 | CNR1 1533/4885CNR2 446/4885ALOX5 128/4885 |
| US-20090053152-A1 | SKIN COSMETIC | TYR, MC1R, MC3R | CNR1 2689/4885CNR2 3120/4885ALOX5 1455/4885 |
| US-20140343328-A1 | PROCESSES FOR MAKING MAGNOLOL ANALOGS | REN, ADRB1, ADRB2 | CNR1 2929/4885CNR2 2107/4885ALOX5 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.